Alembic Pharma receives US FDA approval for generic Tarceva tablets
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for erlotinib tablets, 25 mg, 100 mg, and 150 mg
Generic Tarceva Tablets | 09/07/2021 | By Darshana | 200
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy